ArticleRSC advances2021
The influence of terpenes on the release of volatile organic compounds and active ingredients to cannabis vaping aerosols.
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Procedural Challenges in the Analysis of Toxic Metals in Electronic Cannabinoid Delivery System Aerosols Produced for Vaping Cannabinoids.Journal of testing and evaluation · 2026Article
- Article
- Flavoring Compound Chemical Class and Vaping Conditions Determine Toxic Carbonyl Emissions from E-Cigarettes.Chemical research in toxicology · 2026Article
- Article
- Exploring Aroma and Flavor Diversity inMolecules (Basel, Switzerland) · 2025Review
- Cannabis consumption conundrum: weighing the risks of vaping and smoking.American journal of physiology. Lung cellular and molecular physiology · 2025Article
- Cannabis concentrate vaping chemistry.Frontiers in toxicology · 2025Review
- Association between exposure to terpene compounds and risk of metabolic syndrome: exploring the potential mediating role of inflammatory response.Frontiers in endocrinology · 2025Article
- "Non-Flavor" Flavors: What Are the Implications of Derived Psychoactive Cannabis Product Marketing?Journal of studies on alcohol and drugs · 2024Article
- Article
- The effect of cannabis-derived terpenes on alveolar macrophage function.Frontiers in toxicology · 2024Article
- High-CBD Cannabis Vapor Attenuates Opioid Reward and Partially Modulates Nociception in Female Rats.Addiction neuroscience · 2023Article
- Comprehensive identification of terpene synthase genes and organ-dependent accumulation of terpenoid volatiles in a traditional medicinal plantPlant biotechnology (Tokyo, Japan) · 2022Article
- Noninvasive systemic biomarkers of e-cigarette or vaping use-associated lung injury: a pilot study.ERJ open research · 2022Article
- Novel ΔChemical research in toxicology · 2022Article
- Cannabis Vaping: Existing and Emerging Modalities, Chemistry, and Pulmonary Toxicology.Chemical research in toxicology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dabbing and vaping cannabis extracts have gained large popularity in the United States as alternatives to cannabis smoking, but diversity in both available products and consumption habits make it difficult to assess consumer exposure to psychoactive ingredients and potentially harmful components. This work studies the how relative ratios of the two primary components of cannabis extracts, Δ
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.